The expression and function of RASAL2 in renal cell carcinoma angiogenesis

Patients with renal cell carcinoma (RCC) often develop resistance to antivascular drugs and eventually succumb to disease. However, the underlying molecular mechanism remains poorly understood. In this study, we demonstrated that RASAL2, a RAS GTPase-activating protein, played a tumor-suppressive ro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hui, Ke, Yue, Yangyang, Wu, Shiqi, Gu, Yanan, Guan, Bing, Wang, Xinyang, Hsieh, Jer-Tsong, Chang, Luke S., He, Dalin, Wu, Kaijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115459/
https://www.ncbi.nlm.nih.gov/pubmed/30158581
http://dx.doi.org/10.1038/s41419-018-0898-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115459/
https://www.ncbi.nlm.nih.gov/pubmed/30158581
http://dx.doi.org/10.1038/s41419-018-0898-x

Ejemplares similares